OriGene Technologies Incorporated

OriGene, a gene discovery company, is engaged in the identification and validation of molecular drug targets. OriGene have developed a proprietary technology for high-throughput gene cloning and have identified numerous genes that are associated with the development of different human disorders. OriGene is actively engaged in establishing research alliances with pharmaceutical and biotech companies to extend our discoveries to the development of gene-based diagnostics and therapeutics.

Contact Details: 6 Taft Court, Suite 100 Rockville MD 20850 United States of America Tel: 301-340-3188 Fax: Email: WWW: www.origene.com/

Loading...

Recent Publications by OriGene Technologies Incorporated:
Application of siRNA against SARS in the rhesus macaque model. Containment of the SARS coronavirus (SCV) outbreak was accompanied by the...	19th June, 2008	OriGene Technologies Inc, Rockville, MD, USA.	Methods Mol Biol. 2008;442:139-58. DOI Direct Link

BioNews Results for OriGene Technologies Incorporated:
In Brief This Week: Dow AgroSciences; Chromatin; OriGene Technologies; Jubliant Biosys; Pacific Biosciences; C	GenomeWeb:  Nov 13 2009 9:54PM Matching: origene technologies
Royal Institute of Technology Adopts OriGene Over-Expression Lysates in Human Proteome Atlas Program	Pharma Live:  Nov 10 2009 2:19AM Matching: origene technologies
Royal Institute of Technology Adopts OriGene Over-Expression Lysates in Human Proteome Atlas Program	KOTA Territory News:  Nov 10 2009 11:59AM Matching: origene technologies
Royal Institute of Technology Adopts OriGene Over-Expression Lysates in Human Proteome Atlas Program	Montana's News Station:  Nov 10 2009 7:07AM Matching: origene technologies
OriGene Technologies' over-expression lysates adopted for Human Protein Atlas project	News-Medical.Net:  Nov 10 2009 6:39PM Matching: origene technologies
Promote your company here: BioNewsCast - Press Release Distribution	→View more OriGene Technologies Incorporated news.

OriGene Technologies Incorporated Patents:
US Patent No.	Title
7115393	Melanocortin-1 receptor and methods of use
7053193	Breast cancer transcription factor gene and uses
6953673	Histamine H2 receptor and uses
6833247	Regulated prostate cancer genes
6780595	Human Tbx20 gene and uses
→View more OriGene Technologies Incorporated patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 306 times since April 2007, the link to the organisation's website has been followed 67 times

Recent Search Terms used to find this page: dharmacon vs origene | Origene technologies | .

Search for more companies in Rockville

Search for more companies in MD

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for OriGene Technologies Incorporated